Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F STEWART

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Topoisomerase I interactive agentsC F Stewart
Cancer Chemotherapy and Pharmacology|January 1, 1994
Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerationsC F Stewart
The Journal of Rheumatology. Supplement|May 1, 1990
Drug-drug interactions with antirheumatic agents: review of selected clinically important interactionsC F Stewart, W E Evans
Clinical Pharmacy|July 1, 1987
Effect of maturation on drug disposition in pediatric patientsC F Stewart, E M Hampton
American Journal of Hospital Pharmacy|November 1, 1989
Biotechnology products: new opportunities and responsibilities for the pharmacistC F Stewart, R A Fleming
American Journal of Hospital Pharmacy|June 1, 1990
Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injectionC F Stewart, R A Fleming
American Journal of Hospital Pharmacy|July 1, 1989
Stability of cisplatin and etoposide in intravenous admixturesC F Stewart, E M Hampton
Clinical Chemistry|September 1, 1986
Fluorescence polarization immunoassay for ethosuximide evaluated and compared with two other immunoassay techniquesC F Stewart, M B Bottorff
Biochimica Et Biophysica Acta|September 28, 1998
Animal models for studying the action of topoisomerase I targeted drugsJ Thompson, C F Stewart, P J Houghton
The Laryngoscope|October 20, 1998
Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patientsA Blitzer, M F Brin, C F Stewart
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Topoisomerase I interactive agentsC F Stewart
Cancer Chemotherapy and Pharmacology|January 1, 1994
Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerationsC F Stewart
The Journal of Rheumatology. Supplement|May 1, 1990
Drug-drug interactions with antirheumatic agents: review of selected clinically important interactionsC F Stewart, W E Evans
Clinical Pharmacy|July 1, 1987
Effect of maturation on drug disposition in pediatric patientsC F Stewart, E M Hampton
American Journal of Hospital Pharmacy|November 1, 1989
Biotechnology products: new opportunities and responsibilities for the pharmacistC F Stewart, R A Fleming
American Journal of Hospital Pharmacy|June 1, 1990
Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injectionC F Stewart, R A Fleming
American Journal of Hospital Pharmacy|July 1, 1989
Stability of cisplatin and etoposide in intravenous admixturesC F Stewart, E M Hampton
Clinical Chemistry|September 1, 1986
Fluorescence polarization immunoassay for ethosuximide evaluated and compared with two other immunoassay techniquesC F Stewart, M B Bottorff
Biochimica Et Biophysica Acta|September 28, 1998
Animal models for studying the action of topoisomerase I targeted drugsJ Thompson, C F Stewart, P J Houghton
The Laryngoscope|October 20, 1998
Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patientsA Blitzer, M F Brin, C F Stewart
Pageof 9